Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial

Stéphanie Lheureux, Mihaela Cristea, Jeffrey P. Bruce, Swati Garg, Michael Cabanero, Gina Mantia-Smaldone, Alexander Olawaiye, Susan Ellard, Johanne I. Weberpals, Andrea E. Wahner Hendrickson, Gini F. Fleming, Stephen Welch, Neesha C. Dhani, Tracy Stockley, Prisni Rath, Katherine Karakasis, Gemma N. Jones, Suzanne Jenkins, Jaime Rodriguez‐Canales, Michaël Tracy, David S.P. Tan, Valerie Bowering, Smitha Udagani, Lisa Wang, Charles A. Kunos, Eric X. Chen, Trevor J. Pugh, Amit M. Oza